Issues in the regulation of dietary supplements

Drug Information Journal

Volumn 35, Issue 2, 2001, Pages 529-538

  Bryan, Q ^a   Coleman, L K ^a   Meisberger, S M ^a   Copmann, T ^a  

^a NONE   (United States)

Author keywords

Dietary supplement; Drug interactions; DSHEA; Pregnancy; Structure function

Indexed keywords

DIET SUPPLEMENTATION; DRUG MARKETING; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; GOOD MANUFACTURING PRACTICE; PREGNANCY; PRIORITY JOURNAL; REVIEW; UNITED STATES;

EID: 0035014241     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150103500223     Document Type: Review

References (26)

1. An FDA guide to dietary supplements
2. Regulations on statements made for dietary supplements concerning the effect of the product on the structure or function of the body; final rule
3. FDA protests cholesterol claims on dietary supplements
4. Alternative therapies for the treatment of childhood cancer
5. Pregnancy/nursing statements for dietary supplements CHPA voluntary labeling program
6. GMPs for dietary supplements: The case for self-regulation
7. Good manufacturing practices for dietary supplements: A necessary step toward assuring product quality
8. Current good manufacturing practice in manufacturing, packing, or holding dietary supplements; proposed rule
9. Patient education and herbal dietary supplements
10. USP hopes to play role in standardizing dietary supplements
11. Aflatoxin contamination of some drug plants
12. Safety issues with herbal medicine
13. Content versus label claims in ephedra-containing dietary supplements
14. News briefs
15. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey
16. Drug interactions with St. John's wort
17. Drug interaction between St. John's wort and cyclosporine
18. Risk of drug interactions with St. John's wort
19. St. John's wort and oral contraceptives